Le Lézard
Classified in: Health
Subjects: HEALTH, GOVERNMENT CONTRACTS

A Critically Important Warning in New Financial Accountability Office Report: Ford Government's Long-Term Care Plan is a House of Cards


TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- The new report on long-term care from Ontario's Financial Accountability Office "FAO" supports what the Ontario Health Coalition has been warning about and more. In the neutral language of accounting, it highlights that there is no actual plan to fund needed health care services in the Ford government's budget. It echoes what the Coalition has been warning for months, indeed for years.

In plain language the bottom line is as follows:

"The bottom line is that the Ford government has planned severe underfunding of health care. In human terms, without a profound change in government policy, it means ongoing neglect of long-term care residents, lengthening wait lists, poor access to care across the health system, and the accelerated siphoning of public funds away from public needs to profit," warned Natalie Mehra, executive director. "Yes, it is fair for the Ford government to say they are in a position of catch up. But this fact was well-known before the last election and the Ford government is responsible for the political choice, leading into the pandemic, to prioritize tax cuts that primarily benefit the already-wealthy and other revenue cuts that deprive needed public services. That was a political choice, not a necessity. It has been made worse by the Ford government's choice throughout the pandemic to give the for-profit operators millions in public funding from which they have taken profits and bonuses without actually improving care."

"More than that, as the FAO report makes clear, the media and Opposition Parties must question on the public's behalf the decision that the Ford government made to dramatically increase the cost per bed to entice for-profit long-term care companies to finally redevelop their outdated beds after they have failed for decades to do so. Why are they now being rewarded for their negligence?" she asked.

"The government has to get out of the pockets of the for-profit long-term care industry. We urgently need the government to act in the public interest, not in the interests of health care privatizers who are getting government contracts across the system. The FAO report underlines the profound damage that has been done and is still being done. It cements that case that Ontarians desperately need a real change in direction. It is entirely unacceptable for our province to continue to leave elderly Ontarians, and those who need health care, to suffer in this way," she said. "It is even more egregious that while patients and residents go without needed care, profit-taking corporations are raking in profits from public funds for health care."

"These are hugely important public policy issues. The current plan of the government is a house of cards. This province needs, finally, real leadership and a mature discussion about what we need and how we can fund it. Ontario has, up until the pandemic, funded health care at among the lowest rates in Canada. To change course is absolutely doable, in fact it is imperative, but we cannot go on pretending that services are going to materialize without the resources, planning and investment to create them. This has to be a top priority," said Ms. Mehra.

With this release, the Ontario Health Coalition issued a briefing note on the key data.

For more information: Natalie Mehra, executive director (416) 230-6402 (cell).



These press releases may also interest you

at 02:27
Market Overview The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...



News published on and distributed by: